February 8, 2012
| eCliniqua > Briefs – Sept. 29, 2008


Briefs – Sept. 29, 2008



CDISC awarded contract for training of FDA reviewers
The Clinical Data Interchange Standards Consortium (
CDISC), announced that the FDA has selected it, via a formal RFP process, to provide training to FDA reviewers of regulatory submissions. The courses to be taught over the next two years will include CDISC Basics, the CDISC Study Data Tabulation Model (SDTM), the CDISC Analysis Data Model (ADaM) and Advanced Topics on CDISC Standards. CDISC and its member partners for this training – Octagon Research Solutions, Destiny Corporation and Maximum Likelihood Solutions – will provide classroom as well as web-based virtual training for the requested courses.

Nextrials expands its executive team
Nextrials Inc. has added Robert Barr and Michelle Dockhorn to its executive staff. In his new position as chief technology officer, Barr will be responsible for the continued features and capabilities expansion of Prism, Nextrials’ flagship clinical trial management software and electronic data capture solution.  He is the former VP of software engineering for ClinPhone.  In the newly created position of VP of global sales and marketing, Dockhorn will direct Nextrials’ business initiatives and communications strategy. For more than 15 years, she has served in many operations, marketing and sales roles in the pharmaceutical industry, most recently as the VP of global sales and marketing at Focus Bio-Inova and IBT Laboratories. 

ACORN appoints Tara Webb senior director of CRO business development
Accelerated Community Oncology Research Network (
ACORN), a national oncology-focused contract research organization (CRO) and clinical trial network, has named Tara Webb as senior director of business development. Edward J. Stepanski, COO of ACORN, said in a press release: "[Webb’s] responsibilities at ACORN CRO will include presenting ACORN's capabilities to pharmaceutical companies and emerging biotechs, forging alliances with key accounts and providing customer service oversight on behalf of clients." Most recently, Webb served as senior director, business development, for i3 Statprobe, where she was responsible for developing new business opportunities and strengthening current client relationships both nationally and internationally.

Good Products and Adlib Software partner in pharmaceutical regulatory submissions
Good Products, a provider of enterprise content management solutions for the pharma, biotech and medical device industries, and Adlib Software, a producer of server-based document conversion, recognition and publishing software, announced an OEM partnership that aims to facilitate regulatory submissions in the pharmaceutical industry and will see the integration of Good Products' electronic document management system g-docs with Adlib Software's Express Server centralized PDF rendering tool. Using the new integrated system, pharmas will be able to store, manage and track regulatory documents and create high quality regulatory submission-ready PDFs with bookmarks and hyperlinks. Read the press release.

Paradigm Spine to implement PharmaPros’ automated trial management solution
Paradigm Spine, a provider of non-fusion and fusion spinal implant solutions, has entered an agreement with PharmaPros to implement the company’s automated trial management solution, Dataflow Manager, for its coflex IDE clinical study and future studies in its pipeline. The product will provide Paradigm Spine with one central interface through which to track and manage all of the clinical information for its study, including clinical data, safety data, medical images, site performance metrics, regulatory documents and reimbursement data.

---------------------

This story first appeared in eCliniqua,one of Bio-IT World’s free e-newsletters. Subscribe here.

 

solution

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .